The suit, filed Thursday in US District Court for the Eastern District of Pennsylvania, claims dozens of pharmaceutical manufacturers including Actavis Pharma Inc., Amneal Pharmaceuticals Inc., Glenmark Pharmaceuticals Inc., and Teva Pharmaceuticals Inc. entered into illegal agreements that led to “staggering” price increases for critical drugs.
The complaint’s allegations stem from information made public in state and federal government investigations involving the pharma companies, and documents filed in pending multidistrict litigation in Pennsylvania, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.